LAUSR

Key Points Question What are the incremental lifetime and phase-specific Medicare costs for older adults with multiple myeloma? Findings In this cohort study of data from 4533 patients with multiple myeloma, the incremental lifetime multiple myeloma cost was $184 495, with the incremental monthly costs being the highest in initial and terminal care phases and lower in continuing care and prediagnosis phases. Although inpatient and outpatient care was the major cost driver in most phases, prescription drugs were the largest cost driver in the continuing care phase. Meaning The findings of this study suggest that multiple myeloma care imposes a substantial economic burden to Medicare, with cost of care varying by phases of the disease continuum.